Globus Medical, Inc. (GMED) |
| 90.16 -1.56 (-1.7%) 01-13 16:00 |
| Open: | 91.21 |
| High: | 92.395 |
| Low: | 88.6 |
| Volume: | 1,108,911 |
| Market Cap: | 12,066(M) |
| PE Ratio: | 29.18 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 101.40 |
| Resistance 1: | 95.02 |
| Pivot price: | 90.07 |
| Support 1: | 84.70 |
| Support 2: | 70.47 |
| 52w High: | 101.4 |
| 52w Low: | 51.79 |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
| EPS | 3.090 |
| Book Value | 32.680 |
| PEG Ratio | 0.00 |
| Gross Profit | 16.785 |
| Profit Margin (%) | 15.30 |
| Operating Margin (%) | 22.21 |
| Return on Assets (ttm) | 6.4 |
| Return on Equity (ttm) | 10.0 |
Mon, 12 Jan 2026
Is Globus Medical (GMED) Priced Attractively After Recent Share Price Steadiness? - Yahoo Finance
Mon, 12 Jan 2026
Globus Medical (GMED) director Norwalk sells $202k in shares - Investing.com
Sun, 11 Jan 2026
Why Globus Medical (GMED) Is Up 8.2% After Raising 2026 Revenue Guidance And Integration Outlook - simplywall.st
Fri, 09 Jan 2026
Globus Medical 2026 Outlook: Why M&A Math Mires The Valuation (NYSE:GMED) - Seeking Alpha
Fri, 09 Jan 2026
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - Yahoo Finance
Fri, 09 Jan 2026
Globus Medical Inc (NYSE:GMED): A GARP Stock with Strong Growth and a Reasonable Price - Chartmill
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |